ArticleRheumatology (Oxford, England)2021

Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal?

Sujoy KhanPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.